Advertisement

Topics

Novo Nordisk, Inc. Company Profile

23:25 EST 4th December 2016 | BioPortfolio

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. Headquartered in Denmark, Novo Nordisk employs more than 29,650 employees in 76 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchange in Copenhagen and its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk-us.com.


News Articles [736 Associated News Articles listed on BioPortfolio]

Im Fokus: Novo Nordisk

Auch wenn die Aktie des dänischen Pharmakonzerns Novo Nordisk in den vergangenen zwei Tagen rund 13% an Wert verloren hat - das langfristige Bild bleibt durchaus positiv. Denn Novo Nordisk ist mit ...

Novo Nordisk: Analysten sind zufrieden

Liebe Leser, für eine Anlage in Novo Nordisk spricht nicht zuletzt die Tatsache, dass Insulin stets gefragt ist. Das Medikament macht rund 80 Prozent der Umsätze bei Novo Nordisk aus und wird in di....

Novo Nordisk: Des einen Freud ist des anderen Leid

Liebe Leser, heutzutage füllen sich die Auftragsbücher der Hersteller von Insulin wie Novo Nordisk fast schon wie von Zauberhand. Zeigt doch der Aktienkurs von Novo Nordisk der vergangenen zehn Ja.....

Novo Nordisk: Korrektur abgeschlossen

Lieber Leser, im Laufe der letzten 7 Tage gab es diverse Studien-Updates von Analysten für Novo Nordisk. Aus gutem Grund: Anfang August senkte Novo Nordisk seine Prognose für das Geschäftsjahr 2016...

Novo Nordisk Falls Sharply After Slashing Growth Forecast

WASHINGTON (dpa-AFX) - Novo Nordisk (NVO) has moved sharply lower during trading on Friday, with the Danish pharmaceutical company slumping by 14.5 percent. With the drop, shares of Novo Nordisk h...

Novo Nordisk: Hat die Börse überreagiert?

Lieber Leser, besonders interessiert hat unsere Leser in dieser Woche die Nachricht von Novo Nordisk. Wir erinnern noch einmal: Vor einigen Wochen hatte Novo Nordisk seine Jahresprognose leicht na...

Novo Nordisk irritiert bzw. Tesla und Uber (Top Media Extended)

Novo Nordisk irritiert >> Bildauswahl durch die BSNgine, zum Originalzusammenhang » (Peer Group Watch Runplugged Running... » TTM Technologies, Inc. und Unimicron... Bittere Pille für Novo Nordisk ...

Novo Nordisk: Jetzt heißt es aufpassen

Die Novo Nordisk Aktie steigt zum Start in die neue Woche um über 1%. Dennoch könnte der Kampf um die 30-Euro-Marke in dieser Woche spannend werden und Anleger von Novo Nordisk müssen weiter stark...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Physicians Total Care, Inc.]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

R HUMAN Novolin R Regular, Human Insulin Injection (recombinant DNA origin) USP 100 units/mL

PubMed Articles [311 Associated PubMed Articles listed on BioPortfolio]

Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemia.

Therapy-related acute myeloid leukemia (T-AML) is associated with poor prognosis after conventional therapy. Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as a treatment f...

Rapid centriole assembly in naegleria reveals conserved roles for both de novo and mentored assembly.

Centrioles are eukaryotic organelles whose number and position are critical for cilia formation and mitosis. Many cell types assemble new centrioles next to existing ones ('templated' or mentored asse...

Replication Errors Made During Oogenesis Lead to Detectable De Novo mtDNA Mutations in Zebrafish Oocytes with a Low mtDNA Copy Number.

Of all pathogenic mitochondrial DNA (mtDNA) mutations in humans, ~25% is de novo, although the occurrence in oocytes has never been directly assessed. We used next generation sequencing to detect poin...

Aneurysm growth and de novo aneurysms during aneurysm surveillance.

OBJECTIVE Many low-risk unruptured intracranial aneurysms (UIAs) are followed for growth with surveillance imaging. Growth of UIAs likely increases the risk of rupture. The incidence and risk factors ...

Scoring of de novo Designed Chemical Entities by Macromolecular Target Prediction.

Computational de novo molecular design and macromolecular target prediction have become routine in applied cheminformatics. In this study, we have generated populations of drug template-derived design...

Clinical Trials [293 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

This is a Randomized, Parallel-Group, Placebo- Controlled, Multicenter Study to Evaluate the Therapeutic Equivalence and Safety of Estradiol Vaginal Tablets 10 mcg and Vagifem® (Estradiol...

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentra...

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and Nov...

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

This trial is conducted in Europe. The aim of this clinical trial is to compare the metabolism of a blood-clotting drug (recombinant Factor XIII) produced by two different manufacturers (N...

Companies [50 Associated Companies listed on BioPortfolio]

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area ...

Novo Nordisk Inc.

More Information about "Novo Nordisk, Inc." on BioPortfolio

We have published hundreds of Novo Nordisk, Inc. news stories on BioPortfolio along with dozens of Novo Nordisk, Inc. Clinical Trials and PubMed Articles about Novo Nordisk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novo Nordisk, Inc. Companies in our database. You can also find out about relevant Novo Nordisk, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record